Press release
Neuropathic Pain Market Growth Factors and Manufacturers
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would be the trend followed by the physical therapy market going forward.
Get Free Sample Copy Of Neuropathic Pain Market Report@ https://www.persistencemarketresearch.com/samples/4149
Reaching the revenues of over US$ 6 Bn at the end of 2019, the global neuropathic pain management market is projected for a healthy CAGR during the forecast period (2019 - 2029). Increasing prevalence of neuropathic pain disorders and growing awareness about pain medication are boosting the demand for pain management drugs.
Pipeline strategies by manufacturers are focused on introducing advanced drugs with minimum side effects to increase market share. For instance, Pfizer sponsored drug Pregabalin, effective in treating neuropathic (nerve) pain resulting from peripheral nerve trauma that is in phase 3 clinical trials. Increasing research and development activities to develop medications for indications such as post-herpetic neuralgia are creating significant opportunities for manufactures to flourish in the market.
Company Profiles
• Pfizer Inc.
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Sanofi S.A
• GlaxoSmithKline plc
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd
• Baxter International Inc
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Neuropathic Pain Market? https://www.persistencemarketresearch.com/methodology/4149
Key Takeaways - Neuropathic Pain Management Market Study
• Attributed to less side effects, tricyclic antidepressant drugs are expected to be popular as compared to opioids and steroids during the forecast period.
• North America is expected to be significant revenue generator owing to emergence of several regional market players and well-developed healthcare infrastructure.
• Retail pharmacies are expected to be dominant distribution channels in the neuropathic pain management market.
Increasing prevalence of diabetic neuropathy and availability of approved neuropathy pain medications have significantly added to the opportunities for market growth, thereby fostering the rate of adoption of neuropathic pain management drugs.
Increasing R&D Spending by Pharmaceuticals Companies Shaping Future
One of the key factors observed to impact the neuropathic pain management market growth is the development of new drugs for treatment of neuropathic and chronic pains. Companies are focusing on clinical trials to develop drugs for efficient treatment of neuropathic pain. For instance, Eli Lilly and Company developed Duloxetine (LY248686) for Diabetic Peripheral Neuropathic Pain (DPNP) that is under phase 4 clinical trial.
Go To "Purchase Now" To Have Our Neuropathic Pain Market Report! https://www.persistencemarketresearch.com/checkout/4149
At the same time, companies are focused on expanding therapeutic applications of drugs such as opioids and steroids for neuropathic pain management without causing any serious side effects to patients. Currently, more than 100 clinical trials are been carried out for pain management. Among those clinical trials, nearly half of the clinical trials are for various indications of neuropathic pain such as diabetic neuropathy and post-herpetic neuralgia.
What Does the Report Cover?
The neuropathic pain management market, a new study from Persistence Market Research, provides unparalleled insights on evolution of the neuropathic pain management market during 2014 - 2018 and presents demand projections during 2019 - 2029 on the basis of drug class (tricyclic anti-depressants, anticonvulsants, SNRI's, capsaicin cream, local anesthesia, opioids, steroids, and others), indication (diabetic neuropathy, trigeminal neuralgia, post-herpetic neuralgia, chemotherapy-induced peripheral neuropathy and others), distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies) across prominent regions (North America, Latin America, Europe, Asia Pacific and MEA).
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropathic Pain Market Growth Factors and Manufacturers here
News-ID: 2736207 • Views: …
More Releases from Persistence Market Research
ADAS Recalibration Services Market Forecast to Skyrocket, Reaching New Heights b …
The ADAS (Advanced Driver Assistance Systems) Recalibration Services Market is experiencing rapid growth, driven by increasing vehicle automation, safety regulations, and the proliferation of sensor-based systems in modern vehicles. ADAS technologies, such as lane departure warning, automatic emergency braking, and adaptive cruise control, rely heavily on sensors and cameras. Even minor collisions or windshield replacements can misalign these systems, necessitating professional recalibration services to ensure accurate functioning.
This upward trend is…
Snow Clearing Vehicles Market Poised to Surge with Unprecedented Expansion by 20 …
Market Overview and Growth Dynamics
The global snow clearing vehicles market has witnessed steady growth in recent years, driven by the increasing need for effective snow management across transportation and residential sectors. With harsher and more unpredictable winters due to climate change, municipalities and private stakeholders are heavily investing in specialized snow removal solutions to ensure road safety and infrastructure longevity.
Key growth drivers include rising investments in smart city infrastructure, expansion…
Caster Wheels Market Set for Explosive Growth, Targeting Record Highs by 2032 - …
Market Overview and Growth Outlook
The caster wheels market is witnessing steady expansion through 2032. This growth is fueled by rising automation, material handling needs, and the widespread use of caster wheels across sectors such as healthcare, food processing, automotive, and aerospace. Key growth drivers include the demand for ergonomic workplace solutions, the increasing use of caster wheels in logistics and warehousing, and the expansion of retail and e-commerce sectors globally.…
Electric Bus Market Poised for Transformation Through Innovation - Persistence M …
Market Overview and Growth Analysis
The electric bus market has witnessed exponential growth in recent years and is projected to continue expanding robustly through 2032. This surge can be attributed to stringent environmental regulations, rising urbanization, and substantial government subsidies aimed at encouraging zero-emission transport.
China remains the undisputed leader in the electric bus market, accounting for more than 80% of global electric bus sales. This dominance is due to aggressive government…
More Releases for Neuropathic
Neuropathic Pain Market: Global Industry Demand, Market Future 2028
Neuropathic Pain Market
“Neuropathic Pain-Epidemiology Forecasting Intelligence” report provides a comprehensive analysis of the Neuropathic Pain epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028.
Our epidemiology services include:
• Incidence and prevalence
• Diagnosis rate, treatment rate and mortality patterns
• Epidemiology-based forecasting and disease trends
• Size of different patient segments in a…
Neuropathic Pain Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H1 2017, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.
Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many other diseases.…
Anticonvulsants for Neuropathic Pain Market unprovoked by 2025
Global Anticonvulsants for Neuropathic Pain Market: Snapshot
Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most…
Neuropathic Pain Market Intelligence Report Offers Growth Prospects
Global Neuropathic Pain Market: Overview
Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also…
Neuropathic Pain Market Estimated to Flourish by 2024
The global neuropathic pain market is segmented on the basis of drug class, indication, and distribution channel. On the basis of drug class, the market has been segmented into Tricyclic Antidepressant, Anticonvulsants, Local Anaesthesia, Opioids, Steroids, and Others. The Anticonvulsants drug class segment is expected to remain the largest segment in the global neuropathic pain market, registering a CAGR of 6.4% in terms of value over the forecast period.
The…
Neuropathic Pain Market grows with rising geriatric population
Global Neuropathic Pain Market: Overview
Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also…
